Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SRSF2 Gene Mutation in Patients With Therapy Related Myelodysplastic Syndromes / Acute Myeloid Leukemia

NCT03894852 is registered in ClinicalTrials.gov with Zeinab Albadry Mohammed Zahran as lead sponsor.

NCT NCT03894852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03894852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SRSF2 Gene Mutation in Patients With Therapy Related Myelodysplastic Syndromes / Acute Myeloid Leukemia
Lead sponsor
Zeinab Albadry Mohammed Zahran
Phase
Observational
Overall status
Completed
Start date
June 2, 2019
Completion date
April 29, 2020
Enrollment
139 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

therapy related myelodysplastic syndrome and therapy related acute myeloid leukemia